These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications. Brampton J; Aaronson PI Cardiovasc Hematol Agents Med Chem; 2016; 14(1):4-22. PubMed ID: 26830724 [TBL] [Abstract][Full Text] [Related]
49. Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension. Landburg PP; Teerlink T; van Beers EJ; Muskiet FA; Kappers-Klunne MC; van Esser JW; Mac Gillavry MR; Biemond BJ; Brandjes DP; Duits AJ; Schnog JJ; Haematologica; 2008 Sep; 93(9):1410-2. PubMed ID: 18641026 [No Abstract] [Full Text] [Related]
51. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Kato GJ; Gladwin MT; Steinberg MH Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951 [TBL] [Abstract][Full Text] [Related]
52. Sickle cell-spherocytosis associated with hemolytic anemia. DE TORREGROSA MV; ORTIZ A; VARGAS D Blood; 1956 Mar; 11(3):260-5. PubMed ID: 13293202 [No Abstract] [Full Text] [Related]
53. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Machado RF; Gladwin MT Br J Haematol; 2005 May; 129(4):449-64. PubMed ID: 15877728 [TBL] [Abstract][Full Text] [Related]
58. Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity". Van Beers EJ; Biemond BJ; Schnog JJ; Am J Hematol; 2010 Mar; 85(3):217; author reply 217-8. PubMed ID: 20029993 [No Abstract] [Full Text] [Related]
59. Prostaglandin E1 in primary pulmonary hypertension. Swan PK; Tibballs J; Duncan AW Crit Care Med; 1986 Jan; 14(1):72-3. PubMed ID: 3940758 [No Abstract] [Full Text] [Related]
60. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy. Morris CR Treat Respir Med; 2006; 5(1):31-45. PubMed ID: 16409014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]